Artificial intelligence has been a significant driver of the stock market over the past three years.

Cloud-computing companies including Oracle Corp., Microsoft Corp. and Meta Platforms Inc. have committed to spend a combined $500 billion on data center leases in the coming years, an astronomical

New rumors of stalled data-center funding have sent Oracle’s stock lower, but some experts argue the negative narrative has gotten too harsh.

Shares of Oracle fell sharply on Wednesday after a report raised fresh questions about financing for one of the company’s flagship artificial intelligence infrastructure projects.

Shares of Medline, which sells medical products such as ECG/EKG machines and post-operation bandages, were up more than 31% in afternoon trade above 38. The Nasdaq-listed stock opened nearly 21% above its IPO price of $29 a share, which marked $6.26 billion raised by the company.

Oracle ( ORCL 2.76%) stock fell as much as 16.5% on Dec. 11 in response to the company's second-quarter fiscal 2026 results. Now, at the time of this writing, Oracle is down roughly 42% from its 52-week high, which was made just three months ago.

Oracle shares fell 5% Wednesday morning after the Financial Times reported that data center investor Blue Owl would not participate in a $10 billion financing for one of Oracle’s artificial intelligence data centers being built for OpenAI in Michigan.

Oracle and Blue Owl ended their partnership to build AI data centers, with talks for a one gigawatt Michigan facility falling apart.

We see 2026 as the year that investors begin to shift their focus from hardware to software positions,” an HSBC analyst wrote.

Oracle share price slumped nearly 12 per cent on Thursday. Nvidia, Microsoft, Micron, and CoreWeave stocks were down between 0.4 per cent and 4.4 per cent in premarket trading.

The shares are down 40% from their peak. Analyst suggest that move may have gone too far.